Chris Van Schravendijk

553 total citations
23 papers, 439 citations indexed

About

Chris Van Schravendijk is a scholar working on Surgery, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Chris Van Schravendijk has authored 23 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Public Health, Environmental and Occupational Health and 7 papers in Genetics. Recurrent topics in Chris Van Schravendijk's work include Pancreatic function and diabetes (10 papers), Innovations in Medical Education (8 papers) and Diabetes and associated disorders (7 papers). Chris Van Schravendijk is often cited by papers focused on Pancreatic function and diabetes (10 papers), Innovations in Medical Education (8 papers) and Diabetes and associated disorders (7 papers). Chris Van Schravendijk collaborates with scholars based in Belgium, Netherlands and United Kingdom. Chris Van Schravendijk's co-authors include Daniël Pipeleers, Frans Schuit, Karen Moens, Zhidong Ling, Daisy Flamez, Frans Gorus, Jouni Hirvonen, Constantin Mircioiu, Bart Van Der Auwera and Xue Hou and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Chris Van Schravendijk

23 papers receiving 423 citations

Peers

Chris Van Schravendijk
Nancy Wei United States
Christopher J. Duff United Kingdom
Fei-Na Chen Taiwan
S. Rasmussen Denmark
Sunil Nayak India
Nelson Rassi Brazil
Keding Hua United States
Mingkai Chen China
Marc Andersen Denmark
Marc Meier Switzerland
Nancy Wei United States
Chris Van Schravendijk
Citations per year, relative to Chris Van Schravendijk Chris Van Schravendijk (= 1×) peers Nancy Wei

Countries citing papers authored by Chris Van Schravendijk

Since Specialization
Citations

This map shows the geographic impact of Chris Van Schravendijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Van Schravendijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Van Schravendijk more than expected).

Fields of papers citing papers by Chris Van Schravendijk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Van Schravendijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Van Schravendijk. The network helps show where Chris Van Schravendijk may publish in the future.

Co-authorship network of co-authors of Chris Van Schravendijk

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Van Schravendijk. A scholar is included among the top collaborators of Chris Van Schravendijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Van Schravendijk. Chris Van Schravendijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saso, Luciano, et al.. (2023). Career Options in the Pharmaceutical and Biomedical Industry. 1 indexed citations
2.
Atkinson, Jeffrey, Kristien De Paépe, Antonio Sánchez–Pozo, et al.. (2016). A Study on How Industrial Pharmacists Rank Competences for Pharmacy Practice: A Case for Industrial Pharmacy Specialization. SHILAP Revista de lepidopterología. 4(1). 13–13. 5 indexed citations
3.
Atkinson, Jeffrey, Kristien De Paépe, Antonio Sánchez–Pozo, et al.. (2016). The Second Round of the PHAR-QA Survey of Competences for Pharmacy Practice. SHILAP Revista de lepidopterología. 4(3). 27–27. 17 indexed citations
4.
Atkinson, Jeffrey, Kristien De Paépe, Antonio Sánchez–Pozo, et al.. (2016). How Do European Pharmacy Students Rank Competences for Practice?. SHILAP Revista de lepidopterología. 4(1). 8–8. 5 indexed citations
5.
Atkinson, Jeffrey, Kristien De Paépe, Antonio Sánchez–Pozo, et al.. (2016). What is a Pharmacist: Opinions of Pharmacy Department Academics and Community Pharmacists on Competences Required for Pharmacy Practice. SHILAP Revista de lepidopterología. 4(1). 12–12. 14 indexed citations
6.
Atkinson, Jeffrey, Kristien De Paépe, Antonio Sánchez–Pozo, et al.. (2015). The PHAR-QA Project: Competency Framework for Pharmacy Practice—First Steps, the Results of the European Network Delphi Round 1. SHILAP Revista de lepidopterología. 3(4). 307–329. 19 indexed citations
7.
Atkinson, Jeffrey, Kristien De Paépe, Antonio Sánchez–Pozo, et al.. (2015). Does the Subject Content of the Pharmacy Degree Course Influence the Community Pharmacist’s Views on Competencies for Practice?. SHILAP Revista de lepidopterología. 3(3). 137–153. 7 indexed citations
8.
März, Richard, et al.. (2013). Tuning research competences for Bologna three cycles in medicine: report of a MEDINE2 European consensus survey. Perspectives on Medical Education. 2(4). 181–195. 25 indexed citations
9.
Gorus, Frans, Ilse Weets, Bart Van Der Auwera, et al.. (2013). Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: Relation to autoantibody status and comparison with Belgian patients. Diabetes Research and Clinical Practice. 103(1). 97–105. 15 indexed citations
10.
Auwera, Bart Van Der, Ilse Vermeulen, Eric V. Balti, et al.. (2012). HLA-A*24 Is an Independent Predictor of 5-Year Progression to Diabetes in Autoantibody-Positive First-Degree Relatives of Type 1 Diabetic Patients. Diabetes. 62(4). 1345–1350. 20 indexed citations
11.
Aminkeng, Folefac, Ilse Weets, Bobby P. C. Koeleman, et al.. (2010). Association of IL-2RA/CD25 with type 1 diabetes in the Belgian population. Human Immunology. 71(12). 1233–1237. 7 indexed citations
12.
Gorus, Frans, et al.. (2010). Development of a multipurpose time-resolved fluorescence immunoassay for rat insulin. Analytical Biochemistry. 404(1). 8–13. 7 indexed citations
13.
Aminkeng, Folefac, Ilse Weets, Erik Quartier, et al.. (2009). IFIH1 gene polymorphisms in type 1 diabetes: Genetic association analysis and genotype–phenotype correlation in the Belgian population. Human Immunology. 70(9). 706–710. 16 indexed citations
14.
Aminkeng, Folefac, Bobby P. C. Koeleman, Erik Quartier, et al.. (2007). TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Human Immunology. 68(8). 690–697. 8 indexed citations
15.
Flamez, Daisy, Karen Moens, Simon A. Hinke, et al.. (2004). Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness. Biochemical Pharmacology. 68(1). 33–39. 22 indexed citations
16.
Moens, Karen, Jung‐Mo Ahn, Chris Van Schravendijk, et al.. (2002). Assessment of the Role of Interstitial Glucagon in the Acute Glucose Secretory Responsiveness of In Situ Pancreatic β-Cells. Diabetes. 51(3). 669–675. 30 indexed citations
17.
Ling, Zhidong, Meng-Chi Chen, Xue Hou, et al.. (1999). Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5. Biochemical Pharmacology. 57(10). 1159–1164. 61 indexed citations
18.
Dinesen, Bo, Michelle Deberg, Bruce H. Frank, et al.. (1998). First direct assay for intact human proinsulin. Clinical Chemistry. 44(7). 1514–1519. 23 indexed citations
19.
Moens, Karen, Daisy Flamez, Chris Van Schravendijk, et al.. (1998). Dual Glucagon Recognition by Pancreatic β-Cells via Glucagon and Glucagon-Like Peptide 1 Receptors. Diabetes. 47(1). 66–72. 84 indexed citations
20.
Ling, Zhidong, et al.. (1998). Effect of Glucose on Production and Release of Proinsulin Conversion Products by Cultured Human Islets1. The Journal of Clinical Endocrinology & Metabolism. 83(4). 1234–1238. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy Wei Breakdown of academic impact, for papers by Christopher J. Duff Breakdown of academic impact, for papers by Fei-Na Chen Breakdown of academic impact, for papers by S. Rasmussen Breakdown of academic impact, for papers by Sunil Nayak Breakdown of academic impact, for papers by Nelson Rassi Breakdown of academic impact, for papers by Keding Hua Breakdown of academic impact, for papers by Mingkai Chen Breakdown of academic impact, for papers by Marc Andersen Breakdown of academic impact, for papers by Marc Meier
Rankless by CCL
2026